scholarly journals Further correction: Synthesis and characterization of TPGS–gemcitabine prodrug micelles for pancreatic cancer therapy

RSC Advances ◽  
2017 ◽  
Vol 7 (28) ◽  
pp. 17367-17367
Author(s):  
Vaibhav Khare ◽  
Wejdan Al. Sakarchi ◽  
Prem N. Gupta ◽  
Anthony D. M. Curtis ◽  
Clare Hoskins
Keyword(s):  
Pancreatic Cancer ◽  
Cancer Therapy ◽  
Synthesis And Characterization ◽  
Pancreatic Cancer Therapy

Further correction for ‘Synthesis and characterization of TPGS–gemcitabine prodrug micelles for pancreatic cancer therapy’ by Vaibhav Khare et al., RSC Adv., 2016, 6, 60126–60137.

scholarly journals Correction: Synthesis and characterization of TPGS–gemcitabine prodrug micelles for pancreatic cancer therapy

RSC Advances ◽  
2017 ◽  
Vol 7 (21) ◽  
pp. 12598-12598 ◽  
Author(s):  
Vaibhav Khare ◽  
Wejdan Al. Sakarchi ◽  
Prem N. Gupta ◽  
Anthony D. M. Curtis ◽  
Clare Hoskins
Keyword(s):  
Pancreatic Cancer ◽  
Cancer Therapy ◽  
Synthesis And Characterization ◽  
Pancreatic Cancer Therapy

Correction for ‘Synthesis and characterization of TPGS–gemcitabine prodrug micelles for pancreatic cancer therapy’ by Vaibhav Khare et al., RSC Adv., 2016, 6, 60126–60137.

scholarly journals Synthesis and characterization of TPGS–gemcitabine prodrug micelles for pancreatic cancer therapy

RSC Advances ◽  
2016 ◽  
Vol 6 (65) ◽  
pp. 60126-60137 ◽  
Author(s):  
Vaibhav Khare ◽  
Wejdan Al. Sakarchi ◽  
Prem N. Gupta ◽  
Anthony D. M. Curtis ◽  
Clare Hoskins
Keyword(s):  
Pancreatic Cancer ◽  
Cancer Therapy ◽  
Synthesis And Characterization ◽  
Drug Conjugate ◽  
Conjugate Formulation ◽  
Pancreatic Cancer Therapy

Evaluation of a novel polymer-drug conjugate formulation in pancreatic cancer.

scholarly journals Discovery and Characterization of Dual Inhibitors of MDM2 and NFAT1 for Pancreatic Cancer Therapy

2018 ◽  
Vol 78 (19) ◽  
pp. 5656-5667 ◽  
Author(s):  
Wei Wang ◽  
Jiang-Jiang Qin ◽  
Sukesh Voruganti ◽  
Bhavitavya Nijampatnam ◽  
Sadanandan E. Velu ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Cancer Therapy ◽  
Dual Inhibitors ◽  
Pancreatic Cancer Therapy

MDM2 Inhibitors for Pancreatic Cancer Therapy

2010 ◽  
Vol 999 (999) ◽  
pp. 1-9
Author(s):  
A. S. Azmi ◽  
P. A. Philip ◽  
K. Almhanna ◽  
F. W. Beck ◽  
Z. K. Kafri ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Cancer Therapy ◽  
Pancreatic Cancer Therapy

290 Novel Mcl-1 inhibitors for pancreatic cancer therapy

2010 ◽  
Vol 8 (7) ◽  
pp. 94
Author(s):  
Z. Nikolovska-Coleska ◽  
N. Bajwa ◽  
M. Liu ◽  
A. Azmi ◽  
J. Stuckey ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Cancer Therapy ◽  
Pancreatic Cancer Therapy

Invadopodia: A potential target for pancreatic cancer therapy

2021 ◽  
Vol 159 ◽  
pp. 103236
Author(s):  
Yan Luo ◽  
Jisheng Hu ◽  
Yong Liu ◽  
Le Li ◽  
Yilong Li ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Cancer Therapy ◽  
Potential Target ◽  
Pancreatic Cancer Therapy

scholarly journals Synthesis and Characterization of Lipophilic Salts of Metformin to Improve Its Repurposing for Cancer Therapy

ACS Omega ◽  
2021 ◽  
Vol 6 (4) ◽  
pp. 2626-2637
Author(s):  
Hiwa K. Saeed ◽  
Yogesh Sutar ◽  
Pratikkumar Patel ◽  
Roopal Bhat ◽  
Sudipta Mallick ◽  
...  
Keyword(s):  
Cancer Therapy ◽  
Synthesis And Characterization

scholarly journals Bazedoxifene as a Novel GP130 Inhibitor for Pancreatic Cancer Therapy

2016 ◽  
Vol 15 (11) ◽  
pp. 2609-2619 ◽  
Author(s):  
Xiaojuan Wu ◽  
Yang Cao ◽  
Hui Xiao ◽  
Chenglong Li ◽  
Jiayuh Lin
Keyword(s):  
Pancreatic Cancer ◽  
Cancer Therapy ◽  
Pancreatic Cancer Therapy
Sign in / Sign up

Export Citation Format

Share Document